Correlation Between Terns Pharmaceuticals and Cognition Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Cognition Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Cognition Therapeutics.

Diversification Opportunities for Terns Pharmaceuticals and Cognition Therapeutics

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Terns and Cognition is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Cognition Therapeutics go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and Cognition Therapeutics

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.83 times more return on investment than Cognition Therapeutics. However, Terns Pharmaceuticals is 1.21 times less risky than Cognition Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Cognition Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  649.00  in Terns Pharmaceuticals on August 25, 2024 and sell it today you would lose (70.00) from holding Terns Pharmaceuticals or give up 10.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  Cognition Therapeutics

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Cognition Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Terns Pharmaceuticals and Cognition Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and Cognition Therapeutics

The main advantage of trading using opposite Terns Pharmaceuticals and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.
The idea behind Terns Pharmaceuticals and Cognition Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume